NVS R&D Expense Growth
Novartis AG Common Stock · R&D Expense Growth
NVS R&D Expense Growth
Latest reported7.18%period ending
NVS FY R&D Growth (YoY) (0.00% → 7.18%)
Latest values, visible window
High-resolution chart · PNG
NVS r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 7.1815% | |
| -11.8635% | |
| 23.9751% | |
| 6.1451% | |
| -3.7751% | |
| -4.4884% | |
| 10.7551% | |
| 1.192% | |
| -7.1911% | |
| 1.164% | |
| -1.6619% | |
| 0.1654% | |
| 5.6241% | |
| -10.383% | |
| 5.656% | |
| 21.4353% | |
| 3.4918% | |
| 12.2395% | |
| 20.8419% | |
| 10.9235% | |
| 15.5347% | |
| 11.3435% | |
| 31.1643% | |
| 12.4604% | |
| -12.3744% | |
| 8.2146% | |
| -6.0825% | |
| 0% |